Impact of stimulating cognitive-motor training on neuropsychological status and quality of life in patients with Parkinson's disease

Motor and non-motor symptoms are identified in the clinical picture of Parkinson's disease (PD). Among its non-motor manifestations, cognitive impairment (CI) and emotional disorders play a special role in PD. It is important to search for new forms and methods of cognitive therapy in patients with PD.

Objective: to analyze neuropsychological status and quality of life (QOL) in PD patients and to evaluate the efficiency of personalized combination therapy with a stimulating cognitive motor training on computer and mobile devices in these patients.

Patients and methods. The investigation enrolled 112 patients with PD. A study group included 56 PD patients who received a cycle of combination therapy with cognitive-motor training on PC and mobile devices; a control group consisted of 56 PD patients who had only a drug therapy cycle. To evaluate neuropsychological status and QOL, the investigators used the Montreal Cognitive Assessment (MoCA), the McNair and Kahn memory self-evaluation scale, the Hospital Anxiety and Depression Scale (HADS), and the 36-Item Short Form Health Survey (SF-36) questionnaire.

Results and discussion. According to MoCA scores, CI of varying severity was diagnosed in the majority of patients: in 75 and 80.4% in the study and control groups, respectively. Depressive syndrome was detected in 53.6 and 64.3% in these groups, respectively. According to the SF-36, the physical status of patients had the greatest effect in reducing their QOL. There were treatment-induced statistically significant positive changes for the following domains: physical functioning (p<0.01), role-physical functioning (p<0.001), pain intensity (p<0.01), general health (p<0.01), role emotional (p<0.0001), and mental health (p<0.01).

Conclusion. The investigation has shown the efficiency of personalized therapy including stimulating cognitive-motor training on computer and mobile devices, which improves neuropsychological status and QOL in patients with PD.

1. Muangpaisan W, Mathews A, Hori H, et al. A systematic review of the worldwide prevalence and incidence of Parkinson’s disease. J Med Assoc Thai. 2011 Jun;94(6):749-55.

2. Levin OS. Clinical epidemiology of Parkinson's disease. In: Illarioshkin SN, Levin OS, editors. Bolezn' Parkinsona i rasstroistva dvizhenii. Rukovodstvo dlya vrachei. Po materialam II Natsional'nogo kongressa [Parkinson's disease and movement disorders. Guide for doctors. According to the materials of the II National Congress]. Moscow; 2011. P. 5-9.

3. Razdorskaya VV, Voskresenskaya ON, Yudina GK. Parkinson's disease in Russia: prevalence and incidence (review). Saratovskii nauchno-meditsinskii zhurnal. 2016;12(3):379-84. (In Russ.).

4. Akshulakova SK, Shashkin ChS, Makhambetov ET, et al. Surgeon treatment of Parkinson’s diaesase. Neirokhirurgiya i nevrologiya Kazakhstana. 2014;37(4):3-5. (In Russ.).

5. Alenikova OA, Likhacheva TV, Svinkovskaya TV. Special aspects of sensomotor integration in Parkinson’s disease patients with levodopa-induced diskinesia. Annaly klinicheskoi i eksperimental'noi nevrologii. 2016;10(4):20-5. (In Russ.).

6. Tien K, Alison J, Gordon W, et al. The spectrum of nonmotor symptoms in early Parkinson disease. Neurology. 2013 Jan;80(3):276-81. doi: 10.1212/WNL.0b013e31827deb74

7. Todorova A, Jenner P, Ray Chaudhuri K. Non-motor Parkinson's: integral to motor Parkinson's, yet often neglected. Pract Neurol. 2014 Oct;14(5):310-22. doi: 10.1136/practneurol-2013-000741. Epub 2014 Apr 3.

8. Swick TJ, Friedman JH, Chaudhuri KR, et al. Associations between severity of motor function and nonmotor symptoms in Parkinson's disease: a post hoc analysis of the RECOVER Study. Eur Neurol. 2014;71(3-4): 140-7. doi: 10.1159/000355019. Epub 2014 Jan 21

9. Sjödahl Hammarlund C, Hagell P, Nilsson MH. Motor and non-motor predictors of illness-related distress in Parkinson's disease. Parkinsonism Relat Disord. 2012 Nov;18(3): 299-302. doi: 10.1016/j.parkreldis.2011.10.015

10. Noyce AJ, Bestwick JP, Silveira-Moriyama L, et al. Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol. 2012 Dec;72(6):893-901. doi: 10.1002/ana.23687. Epub 2012 Oct 15

11. Parfenov VA, Starchina YuA. Cognitive impairments in patients with arterial hypertension and treatment. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2011;3(1): 27-33. (In Russ.). doi: 10.14412/2074-27112011-130

12. Nasreddine ZS, Phillipse NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCa: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005 Apr;53(4): 695-9. doi: 10.1111/j.1532-5415.2005.53221.x

13. McNair D, Kahn R. Self-assessment of cognitive deficits. In: Ferris NS, Bartus R, editors. Assessment in geriatric psychopharmacology. Mark Powley; 1983. P. 137–43.

14. Zigmond AS, Snaith RP. The Hospital Anxiety And Depression Scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70.

15. Novik AA, Ionova TI. Rukovodstvo po issledovaniyu kachestva zhizni v meditsine [Guidelines for the study of quality of life in medicine]. Moscow: OLMA-PRESS; 2002. 313 p.

16. Rudnev VA, Okladnikov VI, Bykov YuN. Referent biological adaptation in stroke patients rehabilitation. Nevrologicheskii zhurnal. 2003;(3):18-20. (In Russ).

17. Bykov YuN. Rehabilitation of patients after ischemic stroke on base of functional analyses of sensor-motor processes and referent biological adaptation. Diss. doct. med. sci. Irkutsk; 2003. 198 p.

18. Bykov YuN. Catamnesis assessment of sensor-motor processes in patients with ischemic stroke. Sibirskii meditsinskii zhurnal. 2002;(5):26-9. (In Russ.).

19. Pokhabov DV, Nesterova YuV, Abramov VG. Speech rehabilitation method in Parkinson’s disease patients. Nevrologicheskii zhurnal. 2014;(5):29-31. (In Russ.).

20. Bender TB, Bykov YuN. Sound stimulator of brain. State registration for PC program. Number of registration: 2017661589. Date: 17.10.2017.

21. Boev VM, Borshchuk EL, Ekimov AK, et al. Rukovodstvo po obespecheniyu resheniya mediko-biologicheskikh zadach s primeneniem programmy Statistica 10,0 [Guide to the solution of bio-medical problems with Statistica 10.0 software]. Orenburg: Yuzhnyi Ural; 2014.

22. Lord S, Galna B, Coleman S, et al. Mild depressive symptoms are associated with gait impairment in early Parkinson's disease. Mov Disord. 2013 May;28(5):634-9. doi: 10.1002/mds.25338. Epub 2013 Feb 6.

23. Khoo TK, Yarnall AJ, Duncan GW, et al. The spectrum of nonmotor symptoms in early Parkinson disease. Neurology. 2013 Jan; 80(3): 276-81. doi: 10.1212/WNL.0b013e31827deb74.

24. Gallagher DA, Lees AJ, Schrag A. What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them? Mov Disord. 2010 Nov; 25(15):2493-500. doi: 10.1002/mds.23394.

25. Garcia-Ruiz PJ, Chaudhuri KR, Martinez-Martin P. Non-motor symptoms of Parkinson's disease A review…from the past. J Neurol Sci. 2014 Mar;338(1-2):30-3. doi: 10.1016/j.jns.2014.01.002. Epub 2014 Jan 8.

26. Kunel'skaya NL, Rezakova NV, Gudkova AA, Gekht AB. A feedback method in clinical practice. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2014;(8):46-50. (In Russ.).

27. Pokhabov DV. Rehabilitation of patients with walking disorders in parkinsonism. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2012;(10-2):20-4. (In Russ.).

28. Ware JE, Snow KK, Kosinski M, Gandek B. Sf-36 Health Survey. Manual and Interpretation Guide. Lincoln: QualityMetric Incorporated; 2000.